Suzanne Michele Bertisch, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Initiation and Maintenance Disorders | 16 | 2023 | 1079 | 3.770 |
Why?
|
Migraine Disorders | 20 | 2024 | 1693 | 3.540 |
Why?
|
Sleep | 27 | 2024 | 4750 | 1.740 |
Why?
|
Headache | 8 | 2024 | 1249 | 1.430 |
Why?
|
Yoga | 5 | 2020 | 281 | 1.260 |
Why?
|
Caffeine | 3 | 2024 | 702 | 1.260 |
Why?
|
Complementary Therapies | 6 | 2012 | 486 | 0.980 |
Why?
|
Sleep Apnea, Obstructive | 10 | 2024 | 1860 | 0.850 |
Why?
|
Restless Legs Syndrome | 2 | 2016 | 233 | 0.830 |
Why?
|
Cardiovascular System | 3 | 2021 | 850 | 0.810 |
Why?
|
Autonomic Nervous System | 3 | 2017 | 697 | 0.780 |
Why?
|
Atherosclerosis | 5 | 2023 | 3518 | 0.630 |
Why?
|
Sleep Deprivation | 3 | 2024 | 840 | 0.600 |
Why?
|
Breathing Exercises | 1 | 2017 | 60 | 0.560 |
Why?
|
Goals | 1 | 2022 | 708 | 0.560 |
Why?
|
Blood Pressure | 5 | 2019 | 8525 | 0.550 |
Why?
|
Hot Flashes | 1 | 2019 | 328 | 0.540 |
Why?
|
Football | 1 | 2022 | 502 | 0.530 |
Why?
|
Integrative Medicine | 1 | 2017 | 87 | 0.520 |
Why?
|
Actigraphy | 6 | 2023 | 518 | 0.500 |
Why?
|
Continuous Positive Airway Pressure | 4 | 2023 | 577 | 0.490 |
Why?
|
Photophobia | 4 | 2019 | 71 | 0.470 |
Why?
|
Heart Rate | 4 | 2019 | 4180 | 0.460 |
Why?
|
Arousal | 1 | 2019 | 1157 | 0.440 |
Why?
|
Hypovolemia | 1 | 2011 | 48 | 0.390 |
Why?
|
Relaxation Therapy | 1 | 2012 | 179 | 0.390 |
Why?
|
Poverty | 3 | 2020 | 2695 | 0.380 |
Why?
|
Prescriptions | 1 | 2014 | 388 | 0.380 |
Why?
|
Meditation | 2 | 2017 | 251 | 0.370 |
Why?
|
Polysomnography | 8 | 2023 | 1825 | 0.370 |
Why?
|
Biofeedback, Psychology | 1 | 2011 | 116 | 0.360 |
Why?
|
Sympathetic Nervous System | 2 | 2017 | 520 | 0.350 |
Why?
|
Adult | 42 | 2024 | 220007 | 0.340 |
Why?
|
Prospective Studies | 15 | 2024 | 54306 | 0.330 |
Why?
|
Middle Aged | 41 | 2024 | 220359 | 0.330 |
Why?
|
Respiration | 2 | 2016 | 1654 | 0.320 |
Why?
|
Public Health | 1 | 2022 | 2653 | 0.320 |
Why?
|
Psychophysiology | 1 | 2009 | 136 | 0.320 |
Why?
|
Acupuncture | 1 | 2009 | 90 | 0.310 |
Why?
|
Nutrition Surveys | 2 | 2014 | 1725 | 0.290 |
Why?
|
Humans | 73 | 2024 | 760613 | 0.290 |
Why?
|
Young Adult | 17 | 2024 | 58748 | 0.290 |
Why?
|
Female | 53 | 2024 | 391246 | 0.280 |
Why?
|
Male | 49 | 2024 | 359718 | 0.280 |
Why?
|
Beverages | 2 | 2024 | 820 | 0.270 |
Why?
|
Stress, Psychological | 2 | 2021 | 4446 | 0.270 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1178 | 0.260 |
Why?
|
Pilot Projects | 4 | 2022 | 8556 | 0.240 |
Why?
|
Placebo Effect | 1 | 2009 | 520 | 0.240 |
Why?
|
Vitamin D | 2 | 2015 | 3291 | 0.240 |
Why?
|
Acetazolamide | 1 | 2024 | 96 | 0.220 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2714 | 0.220 |
Why?
|
Cardiovascular Diseases | 3 | 2019 | 15760 | 0.210 |
Why?
|
Sleep Apnea, Central | 2 | 2017 | 88 | 0.210 |
Why?
|
Patients | 1 | 2009 | 906 | 0.200 |
Why?
|
Overweight | 2 | 2016 | 2421 | 0.200 |
Why?
|
Schools | 2 | 2021 | 1480 | 0.200 |
Why?
|
Weather | 2 | 2020 | 226 | 0.190 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6659 | 0.190 |
Why?
|
Cross-Over Studies | 2 | 2024 | 2061 | 0.190 |
Why?
|
Sleep Apnea Syndromes | 3 | 2021 | 974 | 0.190 |
Why?
|
Logistic Models | 3 | 2022 | 13312 | 0.190 |
Why?
|
Students | 2 | 2022 | 1730 | 0.190 |
Why?
|
Minority Groups | 2 | 2020 | 1201 | 0.190 |
Why?
|
Depression | 1 | 2021 | 8045 | 0.190 |
Why?
|
Social Work | 1 | 2022 | 158 | 0.180 |
Why?
|
Trazodone | 1 | 2020 | 68 | 0.180 |
Why?
|
Cohort Studies | 7 | 2020 | 41337 | 0.180 |
Why?
|
Exercise | 4 | 2023 | 5787 | 0.180 |
Why?
|
Sleep Arousal Disorders | 1 | 2019 | 12 | 0.170 |
Why?
|
Aged | 18 | 2023 | 169143 | 0.160 |
Why?
|
Alcoholic Beverages | 1 | 2020 | 264 | 0.160 |
Why?
|
Electroretinography | 2 | 2019 | 517 | 0.150 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2021 | 277 | 0.150 |
Why?
|
Dark Adaptation | 1 | 2019 | 221 | 0.150 |
Why?
|
Color Perception | 1 | 2018 | 212 | 0.150 |
Why?
|
Evoked Potentials, Visual | 2 | 2019 | 415 | 0.140 |
Why?
|
Sex Factors | 3 | 2021 | 10546 | 0.140 |
Why?
|
Focus Groups | 2 | 2020 | 1378 | 0.140 |
Why?
|
Alcohol Drinking | 2 | 2020 | 4013 | 0.140 |
Why?
|
Behavior Therapy | 1 | 2022 | 868 | 0.140 |
Why?
|
Depressive Disorder | 1 | 2009 | 3726 | 0.130 |
Why?
|
Air Pollution | 2 | 2020 | 2317 | 0.130 |
Why?
|
Valsalva Maneuver | 1 | 2016 | 99 | 0.130 |
Why?
|
Health Status | 1 | 2009 | 4082 | 0.130 |
Why?
|
Tai Ji | 1 | 2019 | 287 | 0.130 |
Why?
|
Health Education | 1 | 2022 | 1049 | 0.130 |
Why?
|
Phytotherapy | 1 | 2017 | 295 | 0.120 |
Why?
|
Housing | 1 | 2020 | 665 | 0.120 |
Why?
|
Baroreflex | 1 | 2016 | 148 | 0.120 |
Why?
|
Risk Factors | 8 | 2021 | 74333 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2016 | 180 | 0.120 |
Why?
|
Community Health Services | 1 | 2020 | 654 | 0.120 |
Why?
|
Light | 2 | 2018 | 1344 | 0.120 |
Why?
|
Child Abuse | 1 | 2023 | 1067 | 0.120 |
Why?
|
Nicotine | 1 | 2019 | 677 | 0.120 |
Why?
|
Time Factors | 5 | 2020 | 40139 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 696 | 0.120 |
Why?
|
Mind-Body Therapies | 1 | 2017 | 265 | 0.110 |
Why?
|
Accidental Falls | 1 | 2021 | 1056 | 0.110 |
Why?
|
Health Care Surveys | 2 | 2012 | 2435 | 0.110 |
Why?
|
Simvastatin | 1 | 2015 | 352 | 0.110 |
Why?
|
Health Behavior | 3 | 2017 | 2622 | 0.110 |
Why?
|
Linear Models | 2 | 2015 | 5877 | 0.100 |
Why?
|
Body Mass Index | 2 | 2019 | 12914 | 0.100 |
Why?
|
Blood Flow Velocity | 1 | 2016 | 1377 | 0.100 |
Why?
|
Aspirin | 1 | 2024 | 3364 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 3985 | 0.100 |
Why?
|
Qualitative Research | 2 | 2020 | 2963 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25941 | 0.100 |
Why?
|
Visual Pathways | 1 | 2016 | 534 | 0.100 |
Why?
|
Hypothalamus | 1 | 2017 | 998 | 0.100 |
Why?
|
Circadian Rhythm | 2 | 2021 | 2570 | 0.100 |
Why?
|
United States | 11 | 2021 | 72448 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58980 | 0.100 |
Why?
|
Sleep Stages | 1 | 2015 | 691 | 0.090 |
Why?
|
Visual Cortex | 1 | 2019 | 1089 | 0.090 |
Why?
|
Hypertension | 1 | 2011 | 8595 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 21391 | 0.090 |
Why?
|
Menopause | 1 | 2019 | 1640 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1673 | 0.090 |
Why?
|
Low Back Pain | 1 | 2019 | 979 | 0.090 |
Why?
|
Rest | 1 | 2016 | 914 | 0.090 |
Why?
|
Retina | 2 | 2019 | 2635 | 0.090 |
Why?
|
Leg | 1 | 2016 | 1091 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 550 | 0.090 |
Why?
|
Coronary Vessels | 1 | 2021 | 3112 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3332 | 0.090 |
Why?
|
Thalamus | 1 | 2016 | 1041 | 0.090 |
Why?
|
Fatigue | 1 | 2016 | 1544 | 0.080 |
Why?
|
Academies and Institutes | 2 | 2021 | 319 | 0.080 |
Why?
|
Psychophysics | 2 | 2019 | 289 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9278 | 0.080 |
Why?
|
Obesity | 2 | 2019 | 12919 | 0.070 |
Why?
|
Health Surveys | 3 | 2020 | 4063 | 0.070 |
Why?
|
Case-Control Studies | 4 | 2020 | 22052 | 0.070 |
Why?
|
Arm Injuries | 1 | 2009 | 156 | 0.070 |
Why?
|
Neurons | 2 | 2017 | 9424 | 0.070 |
Why?
|
Disclosure | 1 | 2012 | 738 | 0.070 |
Why?
|
Mortality | 1 | 2018 | 2916 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2022 | 64981 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10553 | 0.070 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2006 | 64 | 0.070 |
Why?
|
Cognition | 2 | 2023 | 6964 | 0.060 |
Why?
|
Age Factors | 3 | 2019 | 18413 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1379 | 0.060 |
Why?
|
Misoprostol | 1 | 2006 | 93 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2315 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10755 | 0.060 |
Why?
|
Adolescent | 9 | 2021 | 87809 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12289 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2017 | 3392 | 0.060 |
Why?
|
Motivation | 1 | 2012 | 1993 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12159 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2024 | 12427 | 0.050 |
Why?
|
Electrocardiography | 1 | 2016 | 6415 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 24102 | 0.050 |
Why?
|
Endocannabinoids | 1 | 2023 | 111 | 0.050 |
Why?
|
Dehydroepiandrosterone | 1 | 2023 | 257 | 0.050 |
Why?
|
Time | 1 | 2023 | 545 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5422 | 0.050 |
Why?
|
Photic Stimulation | 2 | 2019 | 1967 | 0.050 |
Why?
|
Insurance, Medigap | 1 | 2020 | 21 | 0.050 |
Why?
|
Prevalence | 2 | 2021 | 15686 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2023 | 599 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2011 | 5201 | 0.050 |
Why?
|
Abortion, Induced | 1 | 2006 | 460 | 0.050 |
Why?
|
Alcohol-Induced Disorders | 1 | 2020 | 27 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12968 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2024 | 6498 | 0.040 |
Why?
|
Child | 3 | 2023 | 79799 | 0.040 |
Why?
|
Azepines | 1 | 2022 | 330 | 0.040 |
Why?
|
Sulfur Dioxide | 1 | 2019 | 177 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2023 | 636 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5209 | 0.040 |
Why?
|
Systems Analysis | 1 | 2019 | 169 | 0.040 |
Why?
|
Health Benefit Plans, Employee | 1 | 2020 | 333 | 0.040 |
Why?
|
Video Recording | 1 | 2023 | 955 | 0.040 |
Why?
|
Mental Recall | 1 | 2023 | 1206 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15840 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2022 | 1036 | 0.030 |
Why?
|
Nitrogen Dioxide | 1 | 2019 | 512 | 0.030 |
Why?
|
Triazoles | 1 | 2022 | 904 | 0.030 |
Why?
|
Color | 1 | 2017 | 298 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2019 | 541 | 0.030 |
Why?
|
Ozone | 1 | 2019 | 477 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 536 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8158 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2023 | 2209 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2021 | 1131 | 0.030 |
Why?
|
Odds Ratio | 2 | 2020 | 9716 | 0.030 |
Why?
|
Action Potentials | 1 | 2022 | 1816 | 0.030 |
Why?
|
Physical Fitness | 1 | 2019 | 732 | 0.030 |
Why?
|
Vehicle Emissions | 1 | 2019 | 653 | 0.030 |
Why?
|
Spinal Cord | 1 | 2022 | 1817 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 2282 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1739 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1522 | 0.030 |
Why?
|
Aging | 2 | 2023 | 8652 | 0.030 |
Why?
|
Environmental Monitoring | 1 | 2019 | 1441 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3839 | 0.030 |
Why?
|
Rats | 2 | 2017 | 23709 | 0.020 |
Why?
|
Urban Population | 1 | 2017 | 2022 | 0.020 |
Why?
|
Arthritis | 1 | 2014 | 666 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3711 | 0.020 |
Why?
|
Models, Neurological | 1 | 2017 | 1758 | 0.020 |
Why?
|
Quality of Life | 2 | 2021 | 13308 | 0.020 |
Why?
|
Communication | 1 | 2023 | 3849 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4538 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 2005 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9288 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3928 | 0.020 |
Why?
|
Particulate Matter | 1 | 2019 | 2559 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2011 | 791 | 0.020 |
Why?
|
Administration, Buccal | 1 | 2006 | 13 | 0.020 |
Why?
|
Administration, Rectal | 1 | 2006 | 70 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2006 | 150 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2006 | 151 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8803 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29746 | 0.020 |
Why?
|
Air Pollutants | 1 | 2019 | 2844 | 0.020 |
Why?
|
Health Promotion | 1 | 2017 | 2207 | 0.020 |
Why?
|
Emotions | 1 | 2017 | 2734 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16548 | 0.020 |
Why?
|
Body Weight | 1 | 2016 | 4611 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6359 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2362 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14494 | 0.010 |
Why?
|
Area Under Curve | 1 | 2006 | 1635 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20080 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29661 | 0.010 |
Why?
|
Animals | 2 | 2017 | 167960 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39262 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10343 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42056 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80345 | 0.010 |
Why?
|